The landscape of ALK alterations in non-small cell lung cancer

被引：0
|
作者：
Desai, A. [1 ]
Mohammed, T. [2 ]
Rakshit, S. [1 ]
Krull, J. [1 ]
机构：
[1] Mayo Clin, Oncol, Rochester, MN USA
[2] Univ Connecticut, Hartford, CT 06112 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
21P
引用
收藏
页码：S707 / S707
页数：1
相关论文
共 50 条
  • [1] The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
    Gristina, Valerio
    La Mantia, Maria
    Iacono, Federica
    Galvano, Antonio
    Russo, Antonio
    Bazan, Viviana
    [J]. PHARMACEUTICALS, 2020, 13 (12) : 1 - 23
  • [2] The Landscape of MET Alterations in Chinese Non-Small Cell Lung Cancer Patients
    Zheng, M.
    Jun, P.
    Wang, S.
    Li, M.
    Mao, N.
    Liu, Y.
    Cheng, T.
    Lan, H.
    Zhao, J.
    Wang, W.
    Hu, J.
    Yao, M.
    Wang, K.
    Qu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S567 - S567
  • [3] TREATMENT LANDSCAPE AND KEY DRIVERS FOR HTA DECISIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITHOUT EGFR OR ALK ALTERATIONS
    Henry, A.
    Hollier-Hann, G.
    Ralston, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S507 - S507
  • [4] Concurrent Genomic Alterations in ALK-Rearranged Non-Small Cell Lung Cancer Patients
    Clave, S.
    Salido, M.
    Gibert, J.
    Hardy-Werbin, M.
    Weingartner, E.
    Hernandez, J.
    Nichol, D.
    Rocha, P.
    Riera, X.
    Blanco, R.
    Bosch-Barrera, J.
    Taus, A.
    Pijuan, L.
    Bellosillo, B.
    Arriola, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S508 - S509
  • [5] Finding a place for ceritinib in the landscape of ALK-positive non-small cell lung cancer
    Shum, Elaine
    Gandhi, Leena
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S215 - S218
  • [6] Evolution in the treatment landscape of non-small cell lung cancer with ALK gene alterations: from the first- to third-generation of ALK inhibitors
    Spagnuolo, Alessia
    Maione, Paolo
    Gridelli, Cesare
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (03) : 231 - 241
  • [7] Sequencing of ALK Inhibitors in ALK+ Non-Small Cell Lung Cancer
    Shirish M. Gadgeel
    [J]. Current Treatment Options in Oncology, 2017, 18
  • [8] Sequencing of ALK Inhibitors in ALK plus Non-Small Cell Lung Cancer
    Gadgeel, Shirish M.
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (06)
  • [9] The Landscape of RET Genomic Alterations in Chinese Non-Small Cell Lung Cancer Patients
    Liu, X.
    Wei, Y.
    Fan, X.
    Ma, M.
    Liu, J.
    Wen, S.
    Li, M.
    Jiang, D.
    Yu, Y.
    Song, L.
    Cui, Q.
    Chen, H.
    Liu, A.
    Wang, K.
    Qu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S556 - S556
  • [10] Fibrinolytic alterations in non-small cell lung cancer
    Pavey, SJ
    Marsh, NA
    Hawson, GAT
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P2265 - P2265
12345